Open The Door

Sign in  Sign up

Join π
use code:

Hits No hits :(
  According to IMARC Group’s latest report, titled “High Content Screening Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the market to register a CAGR of around 8% during 2020-2025.

High-content screening (HCS), or cellomics, refers to the analytical method that combines automated imaging and quantitative data analysis to evaluate various biochemical and physical characteristics of sample cells. It aids in drug discovery, complex multivariate drug profiling and toxicity studies by utilizing robots, detectors and software to monitor the entire process.

Get a PDF Sample for more detailed market insights:

Market Trends

The key factor driving the global HCS market is the rising cases of chronic diseases like HIV-AIDS, epilepsy, and Parkinson’s diseases, which require intensive treatment. HCS solutions are inexpensive, resource- and time-efficient, and needed for determining the toxicity of chemicals and complex substances in the pharmaceutical industry. Moreover, several leading manufacturers are developing innovative HCS equipment integrated with software platforms and artificial intelligence (AI) systems to enhance the visualization capabilities of the devices. These technological advancements are expected to create a positive outlook for the market in the coming years.

For more information about this report:

Who shared Key for this Door